This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Lactobacillus acidophilus
- DrugBank Accession Number
- DB15823
- Background
Not Available
- Type
- Biotech
- Groups
- Approved, Experimental
- Synonyms
- Acidophilus
- Bacillus acidophilus whole
- Bacterium acidophilum whole
- Lacteol
- Lactobacillus acidophilus
- Lactobacillus acidophilus whole
- Lactobacterium acidophilum whole
- Thermobacterium intestinale whole
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Treatment of Diarrhea •••••••••••• •••••••• ••• •••••••• Maintenance of Intestinal bacteria flora ••• ••• ••••• ••••••• Used in combination to treat Vaginal discharge Combination Product in combination with: Estriol (DB04573) •••••••••••• ••••• •••••••••••• •••••• Used in combination to treat Vaginal flora imbalance Combination Product in combination with: Estriol (DB04573) •••••••••••• ••••• ••••••••••••• ••••••• •••••••••••• •••••• Used as adjunct in combination for symptomatic treatment of Vaginal symptoms Combination Product in combination with: Estriol (DB04573) •••••••••••• ••••• •••••••••••• •••••• - Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Probiata Tablets Tablet 1 b Oral Purity Life Health Products A Division Of Sunopta Inc. 2001-09-01 2007-07-26 Canada 
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Acidophilus Bifidum Bulgaricus Lactobacillus acidophilus (120 mg) + Bifidobacterium bifidum (120 mg) + Lactobacillus delbrueckii bulgaricus (120 mg) Capsule Oral Nutraceutical Corporation 2003-09-02 2006-08-02 Canada Gynoflor - Vaginaltabletten Lactobacillus acidophilus (50 mg) + Estriol (0.03 mg) Tablet Vaginal Gedeon Richter Plc 1990-02-09 Not applicable Austria 
GYNOFLOR 50 MG/0.03 MG VAJİNAL TABLET, 12 ADET Lactobacillus acidophilus (50 mg) + Estriol (0.03 mg) Suppository Vaginal ABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş. 1996-12-11 Not applicable Turkey 
GYNOFLOR 50 MG/0.03 MG VAJİNAL TABLET, 6 ADET Lactobacillus acidophilus (50 mg) + Estriol (0.03 mg) Suppository Vaginal ABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş. 1996-12-11 Not applicable Turkey MORELAC Lactobacillus acidophilus (10000000 CFU) + Lactobacillus delbrueckii bulgaricus (5000000 CFU) + Streptococcus thermophilus (4000000000 CFU) Powder, for suspension Oral Proge Farm S.R.L. 2014-07-08 Not applicable Italy 
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 1PRR1V42V5
- CAS number
- 68333-16-4
References
- General References
- Not Available
- External Links
- 6205
- Wikipedia
- Lactobacillus_acidophilus
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Other Allergic Rhinitis (AR) 1 4 Completed Treatment Bacterial Vaginosis (BV) / Recurrences 1 4 Completed Treatment Diarrhoea Predominant Irritable Bowel Syndrome 1 4 Completed Treatment Probiotics / Type 1 Diabetes Mellitus 1 4 Not Yet Recruiting Treatment Type 2 Diabetes Mellitus With Complication 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Tablet Vaginal Powder, for suspension Oral Capsule Oral 8000000000 [CFU]/1 Capsule Oral 16000000000 [CFU]/1 Tablet Vaginal 66.667 mg Suppository Vaginal Tablet Oral Capsule Oral 20000000000 [CFU]/1 Tablet Vaginal Tablet Oral 1 b Capsule Oral Capsule Oral 2 b / cap Capsule Oral 10000000000 [CFU]/1 - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at September 10, 2020 16:02 / Updated at September 13, 2020 19:13